{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T10:32:35Z","timestamp":1790850755460,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["New Penta srl"],"award-info":[{"award-number":["New Penta srl"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["IRCCS San Raffaele Institutional fundings (Ricerca Corrente)"],"award-info":[{"award-number":["IRCCS San Raffaele Institutional fundings (Ricerca Corrente)"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Migraine is the second world\u2019s cause of disability. Among non-pharmacological treatments, nutritional intervention, particularly ketogenic diet, represents one of the most promising approaches.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This a prospective, single center, randomized, controlled study aimed at evaluating the efficacy of a very low-calorie ketogenic diet (VLCKD) compared to a hypocaloric balanced diet (HBD) in migraine prophylaxis in patients affected by high-frequency episodic migraine (HFEM) with a Body Mass Index (BMI)\u2009&gt;\u200927\u00a0kg\/m<jats:sup>2<\/jats:sup>. Fifty-seven patients were randomly assigned to a VLCKD (group 1) or HBD (group 2). Group 1 patients followed a VLCKD for 8\u00a0weeks, followed by a low calorie diet (LCD, weeks 9\u201312), and a HBD (weeks 13\u201324), whereas group 2 patients followed a HBD from week 0 to 24. Anthropometric indexes, urine and blood chemistry were assessed at enrollment, baseline, weeks 4, 8, 12, and 24. Migraine characteristics were evaluated at baseline, weeks 8, 12 and 24. Change in monthly migraine days (MMDs) at weeks 5\u20138 compared to baseline was the primary endpoint. Secondary endpoints encompassed changes in visual analogue scale (VAS), Headache Impact Test-6 (HIT-6) and Short Form Health Survey-36 (SF-36) scores. We also studied effects on circulating lymphocytes and markers of inflammation, changes in plasma aldosterone and renin levels before and after VLCKD or HBD treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Reduction from baseline in MMDs was greater in VLCKD compared to HBD group at week 8 (p\u2009=\u20090.008), at week 12 (p\u2009=\u20090.007), when ketosis had been interrupted by carbohydrates reintroduction, and at week 24 (p\u2009=\u20090.042), when all patients were following the same dietary regimen. Quality of life scores (SF-36) were improved in VLCKD group at week 8 and 12, and were also improved in HBD group, but only at week 12. Weight-loss was significantly higher in VLCKD group at week 8 (p\u2009=\u20090.002) and week 12 (p\u2009=\u20090.020). At the end of the study weight loss was maintained in VLCKD group whereas a slight weight regain was observed in HBD group. Inflammatory indexes, namely C reactive protein (CRP), neutrophil to lymphocyte ratio (NLR) and total white blood cell count (WBC) were significantly reduced (p\u2009&lt;\u20090.05) in VLCKD group at week 12. Aldosterone plasma level were significantly increased in both groups at week 8, particularly in VLCKD group. However, electrolytes and renin plasma levels were never altered throughout the study in both groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>VLCKD is more effective than HBD in reducing MMD in patients with HFEM and represents an effective prophylaxis in patients with overweight\/obesity.<\/jats:p>\n                <jats:p><jats:italic>Trial registration<\/jats:italic> ClinicalTrials.gov identifier: NCT04360148.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-023-04561-1","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T08:01:50Z","timestamp":1696406510000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Very-low-calorie ketogenic diet vs hypocaloric balanced diet in the prevention of high-frequency episodic migraine: the EMIKETO randomized, controlled trial"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0722-7163","authenticated-orcid":false,"given":"Massimiliano","family":"Caprio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Moriconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Camajani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Feraco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Marzolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Vitiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Proietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Armani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Gorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Mammi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Egeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Aurilia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Fiorentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Tomino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Barbanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,4]]},"reference":[{"key":"4561_CR1","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","volume":"390","author":"T Vos","year":"2017","unstructured":"Vos T, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, Abdulkader RS, Abdulle AM, Abebo TA, Abera SF, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390:1211\u201359. https:\/\/doi.org\/10.1016\/S0140-6736(17)32154-2.","journal-title":"Lancet"},{"key":"4561_CR2","doi-asserted-by":"publisher","first-page":"6619","DOI":"10.1523\/JNEUROSCI.0373-15.2015","volume":"35","author":"R Burstein","year":"2015","unstructured":"Burstein R, Noseda R, Borsook D. Migraine: multiple processes, complex pathophysiology. J Neurosci. 2015;35:6619\u201329. https:\/\/doi.org\/10.1523\/JNEUROSCI.0373-15.2015.","journal-title":"J Neurosci"},{"key":"4561_CR3","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s11916-011-0233-z","volume":"16","author":"Z Katsarava","year":"2012","unstructured":"Katsarava Z, Buse DC, Manack AN, Lipton RB. Defining the differences between episodic migraine and chronic migraine. Curr Pain Headache Rep. 2012;16:86\u201392. https:\/\/doi.org\/10.1007\/s11916-011-0233-z.","journal-title":"Curr Pain Headache Rep"},{"issue":"1","key":"4561_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","author":"Headache classification committee of the international headache society (IHS)","year":"2018","unstructured":"Headache classification committee of the international headache society (IHS). The international classification of headache disorders, 3rd Edition. Cephalalgia. 2018;38(1):1\u2013211. https:\/\/doi.org\/10.1177\/0333102417738202.","journal-title":"Cephalalgia"},{"key":"4561_CR5","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.ncl.2019.06.001","volume":"37","author":"RC Burch","year":"2019","unstructured":"Burch RC, Buse DC, Lipton RB. Migraine. Neurol Clin. 2019;37:631\u201349. https:\/\/doi.org\/10.1016\/j.ncl.2019.06.001.","journal-title":"Neurol Clin"},{"key":"4561_CR6","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/j.1526-4610.2008.01217.x","volume":"48","author":"ME Bigal","year":"2008","unstructured":"Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache J Head Face Pain. 2008;48:1157\u201368. https:\/\/doi.org\/10.1111\/j.1526-4610.2008.01217.x.","journal-title":"Headache J Head Face Pain"},{"key":"4561_CR7","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00415-016-8031-5","volume":"263","author":"YW Woldeamanuel","year":"2016","unstructured":"Woldeamanuel YW, Cowan RP. The impact of regular lifestyle behavior in migraine: a prevalence case-referent study. J Neurol. 2016;263:669\u201376. https:\/\/doi.org\/10.1007\/s00415-016-8031-5.","journal-title":"J Neurol"},{"key":"4561_CR8","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1111\/j.1526-4610.2006.00577.x","volume":"46","author":"ME Bigal","year":"2006","unstructured":"Bigal ME, Lipton RB. Modifiable risk factors for migraine progression. Headache J Head Face Pain. 2006;46:1334\u201343. https:\/\/doi.org\/10.1111\/j.1526-4610.2006.00577.x.","journal-title":"Headache J Head Face Pain"},{"key":"4561_CR9","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.neurol.2012.11.009","volume":"169","author":"P Giraud","year":"2013","unstructured":"Giraud P, Chauvet S. Migraine and obesity, is there a link? Revue Neurologique. 2013;169:413\u20138. https:\/\/doi.org\/10.1016\/j.neurol.2012.11.009.","journal-title":"Revue Neurologique"},{"key":"4561_CR10","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3949\/ccjm.86a.19009","volume":"86","author":"J Robblee","year":"2019","unstructured":"Robblee J, Starling AJ. SEEDS for success: lifestyle management in migraine. Cleve Clin J Med. 2019;86:741\u20139. https:\/\/doi.org\/10.3949\/ccjm.86a.19009.","journal-title":"Cleve Clin J Med"},{"key":"4561_CR11","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S1474-4422(22)00211-3","volume":"21","author":"EK Seng","year":"2022","unstructured":"Seng EK, Martin PR, Houle TT. Lifestyle factors and migraine. Lancet Neurol. 2022;21:911\u201321. https:\/\/doi.org\/10.1016\/S1474-4422(22)00211-3.","journal-title":"Lancet Neurol"},{"key":"4561_CR12","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s10194-022-01498-6","volume":"23","author":"P Barbanti","year":"2022","unstructured":"Barbanti P, Egeo G, Aurilia C, Altamura C, d\u2019Onofrio F, Finocchi C, Albanese M, Aguggia M, Rao R, Zucco M, et al. Predictors of response to anti-cgrp monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients. J Headache Pain. 2022;23:138. https:\/\/doi.org\/10.1186\/s10194-022-01498-6.","journal-title":"J Headache Pain"},{"key":"4561_CR13","doi-asserted-by":"publisher","first-page":"719467","DOI":"10.3389\/fneur.2022.719467","volume":"13","author":"M Agbetou","year":"2022","unstructured":"Agbetou M, Adoukonou T. Lifestyle modifications for migraine management. Front Neurol. 2022;13:719467. https:\/\/doi.org\/10.3389\/fneur.2022.719467.","journal-title":"Front Neurol"},{"key":"4561_CR14","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.3390\/nu13072307","volume":"13","author":"C Di Lorenzo","year":"2021","unstructured":"Di Lorenzo C, Ballerini G, Barbanti P, Bernardini A, D\u2019Arrigo G, Egeo G, Frediani F, Garbo R, Pierangeli G, Prudenzano MP, et al. Applications of ketogenic diets in patients with headache: clinical recommendations. Nutrients. 2021;13:2307. https:\/\/doi.org\/10.3390\/nu13072307.","journal-title":"Nutrients"},{"key":"4561_CR15","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1111\/head.12953","volume":"56","author":"VT Martin","year":"2016","unstructured":"Martin VT, Vij B. Diet and headache: part 1. Headache. 2016;56:1543\u201352. https:\/\/doi.org\/10.1111\/head.12953.","journal-title":"Headache"},{"key":"4561_CR16","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.3390\/nu12061658","volume":"12","author":"P Gazerani","year":"2020","unstructured":"Gazerani P. Migraine and diet. Nutrients. 2020;12:1658. https:\/\/doi.org\/10.3390\/nu12061658.","journal-title":"Nutrients"},{"key":"4561_CR17","doi-asserted-by":"publisher","DOI":"10.5505\/agri.2017.62443","author":"G Evcili","year":"2018","unstructured":"Evcili G. Early and long period follow-up results of low-glycemic index diet for migraine prophylaxis. Agri. 2018. https:\/\/doi.org\/10.5505\/agri.2017.62443.","journal-title":"Agri"},{"key":"4561_CR18","first-page":"308","volume":"2","author":"RM Wilder","year":"1921","unstructured":"Wilder RM. High fat diets in epilepsy. Mayo Clin Bull. 1921;2:308.","journal-title":"Mayo Clin Bull"},{"key":"4561_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/nu14091952","volume":"2022","author":"D Pietrzak","year":"1952","unstructured":"Pietrzak D, Kasperek K, R\u0119kawek P, Pi\u0105tkowska-Chmiel I. The therapeutic role of ketogenic diet in neurological disorders. Nutrients. 1952;2022:14. https:\/\/doi.org\/10.3390\/nu14091952.","journal-title":"Nutrients"},{"key":"4561_CR20","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1007\/s40618-019-01061-2","volume":"42","author":"M Caprio","year":"2019","unstructured":"Caprio M, Infante M, Moriconi E, Armani A, Fabbri A, Mantovani G, Mariani S, Lubrano C, Poggiogalle E, Migliaccio S, et al. Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian society of endocrinology (SIE). J Endocrinol Invest. 2019;42:1365\u201386. https:\/\/doi.org\/10.1007\/s40618-019-01061-2.","journal-title":"J Endocrinol Invest"},{"key":"4561_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10072-017-2889-6","volume":"38","author":"P Barbanti","year":"2017","unstructured":"Barbanti P, Fofi L, Aurilia C, Egeo G, Caprio M. Ketogenic diet in migraine: rationale findings and perspectives. Neurol Sci. 2017;38:111\u20135. https:\/\/doi.org\/10.1007\/s10072-017-2889-6.","journal-title":"Neurol Sci"},{"key":"4561_CR22","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neulet.2008.01.032","volume":"434","author":"M de Almeida","year":"2008","unstructured":"de Almeida M, Oliveira R, da Rocha T, Ata\u00edde SL, de Oliveira A, de Melo L, Lucena CE, Rodrigues P, de Lira A, Soares A, Santos CB, de Almeida A. Effects of short-term and long-term treatment with medium- and long-chain triglycerides ketogenic diet on cortical spreading depression in young rats. Neurosci Lett. 2008;434:66\u201370. https:\/\/doi.org\/10.1016\/j.neulet.2008.01.032.","journal-title":"Neurosci Lett"},{"key":"4561_CR23","doi-asserted-by":"publisher","first-page":"68639810","DOI":"10.3389\/fneur.2021.686398","volume":"12","author":"E Rivera-Mancilla","year":"2021","unstructured":"Rivera-Mancilla E, Al-Hassany L, Villal\u00f3n CM, MaassenVanDenBrink A. Metabolic aspects of migraine: association with obesity and diabetes mellitus. Front Neurol. 2021;12:68639810. https:\/\/doi.org\/10.3389\/fneur.2021.686398.","journal-title":"Front Neurol"},{"key":"4561_CR24","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/0196-9781(91)90147-H","volume":"12","author":"PMJ Zelissen","year":"1991","unstructured":"Zelissen PMJ, Koppeschaar HPF, Lips CJM, Hackeng WHL. Calcitonin gene-related peptide in human obesity. Peptides. 1991;12:861\u20133. https:\/\/doi.org\/10.1016\/0196-9781(91)90147-H.","journal-title":"Peptides"},{"key":"4561_CR25","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1212\/01.wnl.0000197218.05284.82","volume":"66","author":"ME Bigal","year":"2006","unstructured":"Bigal ME, Liberman JN, Lipton RB. Obesity and migraine: a population study. Neurology. 2006;66:545\u201350. https:\/\/doi.org\/10.1212\/01.wnl.0000197218.05284.82.","journal-title":"Neurology"},{"key":"4561_CR26","volume-title":"Comprehensive physiology","author":"M Infante","year":"2017","unstructured":"Infante M, Armani A, Mammi C, Fabbri A, Caprio M. Impact of adrenal steroids on regulation of adipose tissue. In: Terjung R, editor. Comprehensive physiology. Hoboken: Wiley; 2017."},{"key":"4561_CR27","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.tem.2019.11.006","volume":"31","author":"A Feraco","year":"2020","unstructured":"Feraco A, Marzolla V, Scuteri A, Armani A, Caprio M. Mineralocorticoid receptors in metabolic syndrome: from physiology to disease. Trends Endocrinol Metab. 2020;31:205\u201317. https:\/\/doi.org\/10.1016\/j.tem.2019.11.006.","journal-title":"Trends Endocrinol Metab"},{"key":"4561_CR28","doi-asserted-by":"publisher","first-page":"S139","DOI":"10.1097\/01.hjh.0000220419.86149.11","volume":"24","author":"E Tronvik","year":"2006","unstructured":"Tronvik E, Stovner LJ, Schrader H, Bovim G. Involvement of the renin-angiotensin system in migraine. J Hypertens. 2006;24:S139\u201343. https:\/\/doi.org\/10.1097\/01.hjh.0000220419.86149.11.","journal-title":"J Hypertens"},{"key":"4561_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11916-019-0823-8","volume":"23","author":"T Dorosch","year":"2019","unstructured":"Dorosch T, Ganzer CA, Lin M, Seifan A. Efficacy of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the preventative treatment of episodic migraine in adults. Curr Pain Headache Rep. 2019;23:85. https:\/\/doi.org\/10.1007\/s11916-019-0823-8.","journal-title":"Curr Pain Headache Rep"},{"issue":"9","key":"4561_CR30","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1177\/0333102417738202","volume":"33","author":"Headache classification committee of the international headache society (IHS)","year":"2013","unstructured":"Headache classification committee of the international headache society (IHS). The international classification of headache disorders, 3rd Edition (Beta Version). Cephalalgia. 2013;33(9):629\u2013808. https:\/\/doi.org\/10.1177\/0333102413485658.","journal-title":"Cephalalgia"},{"key":"4561_CR31","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1177\/0333102416630579","volume":"36","author":"P Barbanti","year":"2016","unstructured":"Barbanti P, Aurilia C, Dall\u2019Armi, V., Egeo, G., Fofi, L., Bonassi, S. The phenotype of migraine with unilateral cranial autonomic symptoms documents increased peripheral and central trigeminal sensitization a case series of 757 patients. Cephalalgia. 2016;36:1334\u201340. https:\/\/doi.org\/10.1177\/0333102416630579.","journal-title":"Cephalalgia"},{"issue":"1","key":"4561_CR32","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.2903\/j.efsa.2015.3957","volume":"13","author":"EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies)","year":"2015","unstructured":"EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies). Scientific Opinion on the essential composition of total diet replacements for weight control. EFSA Journal. 2015;13(1):3957 https:\/\/doi.org\/10.2903\/j.efsa.2015.3957.","journal-title":"EFSA Journal"},{"key":"4561_CR33","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3389\/fendo.2020.00444","volume":"11","author":"E Moriconi","year":"2020","unstructured":"Moriconi E, Feraco A, Marzolla V, Infante M, Lombardo M, Fabbri A, Caprio M. Neuroendocrine and metabolic effects of low-calorie and non-calorie sweeteners. Front Endocrinol. 2020;11:444. https:\/\/doi.org\/10.3389\/fendo.2020.00444.","journal-title":"Front Endocrinol"},{"key":"4561_CR34","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s13668-018-0235-0","volume":"7","author":"VM Gershuni","year":"2018","unstructured":"Gershuni VM, Yan SL, Medici V. Nutritional ketosis for weight management and reversal of metabolic syndrome. Curr Nutr Rep. 2018;7:97\u2013106. https:\/\/doi.org\/10.1007\/s13668-018-0235-0.","journal-title":"Curr Nutr Rep"},{"key":"4561_CR35","doi-asserted-by":"publisher","first-page":"e088","DOI":"10.5435\/JAAOSGlobal-D-17-00088","volume":"2","author":"DA Delgado","year":"2018","unstructured":"Delgado DA, Lambert BS, Boutris N, McCulloch PC, Robbins AB, Moreno MR, Harris JD. Validation of digital visual analog scale pain scoring with a traditional paper-based visual analog scale in adults. J Am Acad Orthop Surg Glob Res Rev. 2018;2:e088. https:\/\/doi.org\/10.5435\/JAAOSGlobal-D-17-00088.","journal-title":"J Am Acad Orthop Surg Glob Res Rev"},{"key":"4561_CR36","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12955-014-0117-0","volume":"12","author":"R Rendas-Baum","year":"2014","unstructured":"Rendas-Baum R, Yang M, Varon SF, Bloudek LM, DeGryse RE, Kosinski M. Validation of the headache impact test (HIT-6) in patients with chronic migraine. Health Qual Life Outcomes. 2014;12:117. https:\/\/doi.org\/10.1186\/s12955-014-0117-0.","journal-title":"Health Qual Life Outcomes"},{"key":"4561_CR37","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1212\/wnl.56.suppl_1.s20","volume":"56","author":"WF Stewart","year":"2001","unstructured":"Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the migraine disability assessment (MIDAS) questionnaire to assess headache-related disability. Neurology. 2001;56:S20-28. https:\/\/doi.org\/10.1212\/wnl.56.suppl_1.s20.","journal-title":"Neurology"},{"key":"4561_CR38","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware","year":"1992","unstructured":"Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473\u201383.","journal-title":"Med Care"},{"key":"4561_CR39","doi-asserted-by":"publisher","first-page":"205031211667172","DOI":"10.1177\/2050312116671725","volume":"4","author":"L Lins","year":"2016","unstructured":"Lins L, Carvalho FM. SF-36 total score as a single measure of health-related quality of life: scoping review. SAGE Open Med. 2016;4:2050312116671725. https:\/\/doi.org\/10.1177\/2050312116671725.","journal-title":"SAGE Open Med"},{"key":"4561_CR40","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3390\/nu13030758","volume":"13","author":"E Moriconi","year":"2021","unstructured":"Moriconi E, Camajani E, Fabbri A, Lenzi A, Caprio M. Very-low-calorie ketogenic diet as a safe and valuable tool for long-term glycemic management in patients with obesity and type 2 diabetes. Nutrients. 2021;13:758. https:\/\/doi.org\/10.3390\/nu13030758.","journal-title":"Nutrients"},{"key":"4561_CR41","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad009","author":"P Belany","year":"2023","unstructured":"Belany P, Kackley ML, Zhao S, Kluwe B, Buga A, Crabtree C, Nedungadi D, Kline D, Brock G, Simonetti OP, et al. Effects of hypocaloric low-fat, ketogenic and ketogenic & ketone supplement diets on aldosterone and renin. J Clin Endocrinol Metab. 2023. https:\/\/doi.org\/10.1210\/clinem\/dgad009.","journal-title":"J Clin Endocrinol Metab"},{"key":"4561_CR42","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.3390\/nu11081742","volume":"11","author":"C Di Lorenzo","year":"2019","unstructured":"Di Lorenzo C, Pinto A, Ienca R, Coppola G, Sirianni G, Di Lorenzo G, Parisi V, Serrao M, Spagnoli A, Vestri A, et al. A randomized double-blind, cross-over trial of very low-calorie diet in overweight migraine patients: a possible role for ketones? Nutrients. 2019;11:1742. https:\/\/doi.org\/10.3390\/nu11081742.","journal-title":"Nutrients"},{"key":"4561_CR43","doi-asserted-by":"publisher","first-page":"4946","DOI":"10.3390\/jcm11174946","volume":"11","author":"M Valente","year":"2022","unstructured":"Valente M, Garbo R, Filippi F, Antonutti A, Ceccarini V, Tereshko Y, Di Lorenzo C, Gigli GL. Migraine prevention through ketogenic diet: more than body mass composition changes. J Clin Med. 2022;11:4946. https:\/\/doi.org\/10.3390\/jcm11174946.","journal-title":"J Clin Med"},{"key":"4561_CR44","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/s41430-021-01060-8","volume":"76","author":"Y Ruan","year":"2022","unstructured":"Ruan Y, Chen L, She D, Chung Y, Ge L, Han L. Ketogenic diet for epilepsy: an overview of systematic review and meta-analysis. Eur J Clin Nutr. 2022;76:1234\u201344. https:\/\/doi.org\/10.1038\/s41430-021-01060-8.","journal-title":"Eur J Clin Nutr"},{"key":"4561_CR45","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3389\/fphar.2012.00059","volume":"3","author":"CE Stafstrom","year":"2012","unstructured":"Stafstrom CE, Rho JM. The ketogenic diet as a treatment paradigm for diverse neurological disorders. Front Pharmacol. 2012;3:59. https:\/\/doi.org\/10.3389\/fphar.2012.00059.","journal-title":"Front Pharmacol"},{"key":"4561_CR46","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1093\/nutrit\/nuaa113","volume":"79","author":"S Pav\u00f3n","year":"2021","unstructured":"Pav\u00f3n S, L\u00e1zaro E, Mart\u00ednez O, Amayra I, L\u00f3pez-Paz JF, Caballero P, Al-Rashaida M, Luna PM, Garc\u00eda M, P\u00e9rez M, et al. Ketogenic diet and cognition in neurological diseases: a systematic review. Nutr Rev. 2021;79:802\u201313. https:\/\/doi.org\/10.1093\/nutrit\/nuaa113.","journal-title":"Nutr Rev"},{"key":"4561_CR47","doi-asserted-by":"publisher","first-page":"105727","DOI":"10.1016\/j.clineuro.2020.105727","volume":"192","author":"N Arora","year":"2020","unstructured":"Arora N, Mehta TR. Role of the ketogenic diet in acute neurological diseases. Clin Neurol Neurosurg. 2020;192:105727. https:\/\/doi.org\/10.1016\/j.clineuro.2020.105727.","journal-title":"Clin Neurol Neurosurg"},{"key":"4561_CR48","doi-asserted-by":"publisher","first-page":"782657","DOI":"10.3389\/fnut.2021.782657","volume":"8","author":"SM Gough","year":"2021","unstructured":"Gough SM, Casella A, Ortega KJ, Hackam AS. Neuroprotection by the ketogenic diet: evidence and controversies. Front Nutr. 2021;8:782657. https:\/\/doi.org\/10.3389\/fnut.2021.782657.","journal-title":"Front Nutr"},{"key":"4561_CR49","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11154-019-09514-y","volume":"21","author":"M Castellana","year":"2020","unstructured":"Castellana M, Conte E, Cignarelli A, Perrini S, Giustina A, Giovanella L, Giorgino F, Trimboli P. Efficacy and safety of very low calorie ketogenic diet (VLCKD) in patients with overweight and obesity: a systematic review and meta-analysis. Rev Endocr Metab Disord. 2020;21:5\u201316. https:\/\/doi.org\/10.1007\/s11154-019-09514-y.","journal-title":"Rev Endocr Metab Disord"},{"key":"4561_CR50","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1080\/1028415X.2017.1416740","volume":"22","author":"KC Schreck","year":"2019","unstructured":"Schreck KC, Lwin M, Strowd RE, Henry-Barron BJ, Blakeley JO, Cervenka MC. Effect of ketogenic diets on leukocyte counts in patients with epilepsy. Nutr Neurosci. 2019;22:522\u20137. https:\/\/doi.org\/10.1080\/1028415X.2017.1416740.","journal-title":"Nutr Neurosci"},{"key":"4561_CR51","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3389\/fimmu.2015.00639","volume":"6","author":"S Omenetti","year":"2015","unstructured":"Omenetti S, Pizarro TT. The Treg\/Th17 axis: a dynamic balance regulated by the gut microbiome. Front Immunol. 2015;6:639. https:\/\/doi.org\/10.3389\/fimmu.2015.00639.","journal-title":"Front Immunol"},{"key":"4561_CR52","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.autrev.2013.12.004","volume":"13","author":"M Noack","year":"2014","unstructured":"Noack M, Miossec P. Th17 and regulatory T cell balance in autoimmune and inflammatory diseases. Autoimmun Rev. 2014;13:668\u201377. https:\/\/doi.org\/10.1016\/j.autrev.2013.12.004.","journal-title":"Autoimmun Rev"},{"key":"4561_CR53","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.seizure.2016.03.006","volume":"38","author":"F-F Ni","year":"2016","unstructured":"Ni F-F, Li C-R, Liao J-X, Wang G-B, Lin S-F, Xia Y, Wen J-L. The effects of ketogenic diet on the Th17\/Treg cells imbalance in patients with intractable childhood epilepsy. Seizure. 2016;38:17\u201322. https:\/\/doi.org\/10.1016\/j.seizure.2016.03.006.","journal-title":"Seizure"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04561-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-04561-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04561-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T01:23:55Z","timestamp":1700443435000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-04561-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,4]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4561"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-04561-1","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,4]]},"assertion":[{"value":"20 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by IRCSS San Raffaele Ethics Committee on January 22, 2020 and carried out in accordance with the Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments that involved humans. The aim of the study was clearly explained to all the study participants and a written informed consent was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consented for publication; written informed consent for publication was obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"EC has received compensation for consultancy from New Penta s.r.l.; MC has received compensation for consultancy from Therascience s.a.m. and New Penta s.r.l.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"692"}}